Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Interest Expenses (2023 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Interest Expenses for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 8.05% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, up 13.27% year-over-year, with the annual reading at $5.3 million for FY2025, 13.27% up from the prior year.
  • Interest Expenses for Q4 2025 was $1.4 million at Werewolf Therapeutics, up from $1.3 million in the prior quarter.
  • The five-year high for Interest Expenses was $1.4 million in Q4 2025, with the low at $172000.0 in Q1 2023.
  • Average Interest Expenses over 3 years is $1.1 million, with a median of $1.2 million recorded in 2024.
  • The sharpest move saw Interest Expenses surged 483.14% in 2024, then grew 7.8% in 2025.
  • Over 3 years, Interest Expenses stood at $1.0 million in 2023, then increased by 25.45% to $1.3 million in 2024, then increased by 8.05% to $1.4 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $1.4 million, $1.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.